← Back to Press PAGE

NHS study to unlock cancer survival secrets

Cure51

Publication Date:

Nov 18, 2024

Cure51 has announced the UK launch of the Rosalind study, a groundbreaking initiative already underway in other parts of Europe that aims to unlock the secrets of exceptional cancer survivors.

Read more

NEWS

THEY SPREAD THE WORD

Go to Press page

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

Defeating cancer: By identifying the biological mechanisms shared by tens of thousands of survivors of the most aggressive forms of cancer.

Aug 16, 2025

Join us to eradicate Cancer.

ROSALIND

NHS study to unlock cancer survival secrets

Publication Date:

Nov 18, 2024

Table of Contents

THEY SPREAD THE WORD

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

Defeating cancer: By identifying the biological mechanisms shared by tens of thousands of survivors of the most aggressive forms of cancer.

Aug 16, 2025